Substance Use Disorder Awareness and Education

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

This webinar discusses trends in THC potency and delivery and their systems, marijuana risks for developing fetal brain systems and adolescent brain, and what to do with this information.

This on-demand webinar reviews research on 12-step mutual help groups for people seeking to recovery from addiction and discusses the mechanisms through which 12-step groups affect members.

This toolkit helps users evaluate their organization's diversity and cultural competence through a step-by-step process.

This handout provides definitions for the most common terms used in discussing why health equity matters in prevention.

This compilation of best practice recommendations and resources provides guidance to initiate and expand MAT programs for OUD for patient populations in a variety of service settings.

This treatment improvement protocol (TIP) provides guidance to counselors, administrators, and supervisors about recovery-oriented services, supports, and care, allowing them to better serve individuals in or seeking recovery from problematic substance use.

This brief presents an overview of trends in substance use disorder treatment between 2015 and 2018 using data from two national surveys.

This brief presents an overview of trends in the prevalence of substance use disorders between 2015 and 2018 across different age groups.

Using a national Medicaid claims database, this brief estimates the number of pregnant beneficiaries with substance use disorder who lost Medicaid coverage 60 days postpartum at the national and state-level.